| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $230.1M | -31.9% |
| Cost of Revenue | $178.4M | -24.5% |
| Gross Profit | $51.6M | -49.0% |
| R&D Expense | $51.6M | -1.5% |
| SG&A Expense | $48.5M | -4.7% |
| Operating Income | -$57.6M | -999.2% |
| Pre-tax Income | -$47.6M | -1551.9% |
| Income Tax | -$10.9M | -312.1% |
| Net Income | -$36.6M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $158.1M | -29.9% |
| Accounts Receivable | $32.6M | -7.7% |
| Inventory | $32.7M | -17.9% |
| Current Assets | $245.4M | -27.4% |
| Total Assets | $420.5M | -18.6% |
| Current Liabilities | $46.9M | -0.8% |
| Total Liabilities | $75.9M | -14.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.0M | -158.4% |
| Capital Expenditures | $7.0M | -70.3% |
| Investing Cash Flow | -$7.7M | +69.3% |
| Financing Cash Flow | -$52.3M | -310.7% |
| Free Cash Flow | -$10.0M | +45.3% |
| -355.7% |
| EPS (Basic) | -$0.89 | -394.4% |
| EPS (Diluted) | -$0.89 | -394.4% |
| Stockholders' Equity |
| $344.6M |
| -19.5% |